drugset / Trial / NCT00516711

Role of Volatile Anesthetics for Hepatic Protection

NCT00516711 ↗

RandomizedParallel-groupOpen-labelPrevention

Summary

This study aims to evaluate the attenuation of ischemic-reperfusion injury in the liver after sevoflurane preconditioning. In the presence of sevoflurane, an attenuation of liver injury is hypothesized (diminished increase of liver enzymes, reduced production of inflammatory mediators).

Timeline

Start
2006-03
Primary completion
2007-12
Completion
2007-12

Outcome

Met primary endpoint

paper Sevoflurane preconditioning significantly limited the postoperative increase of serum transaminase levels by 261 U/L (95% CI, 65 to 458; P = 0.01) PMID 19092335 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Sevoflurane Other / unclassified — —

Indications

No indication recorded.